Secondary |
Psoriatic Arthropathy |
32.5% |
Neuralgia |
22.5% |
Pain |
12.5% |
Insomnia |
10.0% |
Reflux Oesophagitis |
7.5% |
Fibromyalgia |
2.5% |
Gastric Disorder |
2.5% |
Gastrooesophageal Reflux Disease |
2.5% |
Product Used For Unknown Indication |
2.5% |
Rheumatoid Arthritis |
2.5% |
Sleep Disorder |
2.5% |
|
Weight Increased |
50.0% |
Increased Appetite |
12.5% |
Laryngeal Oedema |
12.5% |
Piriformis Syndrome |
12.5% |
Tooth Avulsion |
12.5% |
|
Concomitant |
Product Used For Unknown Indication |
29.7% |
Prophylaxis |
13.6% |
Pain |
10.1% |
Rheumatoid Arthritis |
10.0% |
Headache |
5.9% |
Drug Use For Unknown Indication |
4.9% |
Hypertension |
3.5% |
Relapsing-remitting Multiple Sclerosis |
3.2% |
Depression |
2.3% |
Prophylaxis Of Nausea And Vomiting |
1.9% |
Premedication |
1.8% |
Rhinitis |
1.8% |
Gastrooesophageal Reflux Disease |
1.6% |
Arthritis |
1.5% |
Diabetes Mellitus |
1.5% |
Gastrooesophageal Reflux Prophylaxis |
1.5% |
Insomnia |
1.4% |
Multiple Sclerosis |
1.4% |
Gastritis |
1.3% |
Pain Prophylaxis |
1.3% |
|
Weight Increased |
18.7% |
Visual Impairment |
7.9% |
Pain |
7.2% |
Weight Decreased |
7.2% |
Vomiting |
5.8% |
Headache |
5.0% |
Urinary Tract Infection |
5.0% |
Dyspnoea |
4.3% |
Fatigue |
4.3% |
Syncope |
4.3% |
Xyy Syndrome |
4.3% |
Urticaria |
3.6% |
Gastrointestinal Perforation |
2.9% |
Hypertension |
2.9% |
Ill-defined Disorder |
2.9% |
Pollakiuria |
2.9% |
Scar |
2.9% |
Tachycardia |
2.9% |
Tremor |
2.9% |
Alanine Aminotransferase Increased |
2.2% |
|
Interacting |
Diabetes Mellitus |
30.8% |
Depression |
23.1% |
Hypertension |
15.4% |
Blood Cholesterol |
7.7% |
Hypothyroidism |
7.7% |
Pain |
7.7% |
Pituitary Tumour Benign |
7.7% |
|
|